XML 65 R54.htm IDEA: XBRL DOCUMENT v3.25.3
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 17, 2025
May 30, 2025
Oct. 31, 2017
Jun. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2024
Jul. 02, 2025
Mar. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000       200,000,000
Common stock, par value           $ 0.001       $ 0.001
Warrants issued to purchase common stock   13,000,000                
Warrants exercise price   $ 1                
Stock options to purchase, granted               400,000    
Options term           10 years        
Description of vesting options           The vesting of the Options was accelerated to be fully vested on May 30, 2025 upon the execution of a separation agreement with our former Chief Executive Officer.        
Remaining expenses related to options           $ 787,826 $ 2,623,031      
Stock based award, unrecognized compensation expense           $ 0        
Stock Option [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Remaining expenses related to options       $ 48,725 $ 33,568   $ 74,623      
Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrant issued to purchase $ 13,000,000 $ 7,000,000                
Warrants outstanding           21,720,345        
Issuance of warrants, description           Each warrant provides the holder the right to purchase one share of our common stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of common stock at an exercise price of $0.01 per share until December 2026; (2) warrants to purchase 59,034 shares of our Common Stock at an exercise price of $2.00 per share until October 2025; (3) warrants to purchase 675,000 shares of our Common Stock at an exercise price of $2.00 per share until February 2026; (4) warrants to purchase 500,000 shares of Common Stock at an exercise price of $2.00 per share until December 2025; (5) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025; (6) warrants to purchase 7,000,000 shares of common stock at an exercise price of $1.81 until May 2030; and (7) warrants to purchase 13,000,000 shares of common stock at an exercise price of $1.00 until September 2030.        
Warrants exercise price $ 1 $ 1.81                
Warrant One [Member] | Until December 2026 [ Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           100,000        
Warrants exercise price           $ 0.01        
Warrant Two [Member] | Until October 2025 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           59,034        
Warrants exercise price           $ 2        
Warrant Three [Member] | Until February 2026 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           675,000        
Warrants exercise price           $ 2        
Warrant Four [Member] | Until December 2025 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           500,000        
Warrants exercise price           $ 2        
Warrant Five [Member] | Until November 2025 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           386,311        
Warrants exercise price           $ 2.63        
Warrant Six [Member] | Until May 2030 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           7,000,000        
Warrants exercise price           $ 1.81        
Warrant Seven [Member] | Until May 2030 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           13,000,000        
Warrants exercise price           $ 1        
2017 Equity Incentive Plan [Member] | October 2020 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Increase in issuance of equity-based instruments     4,515,000              
2017 Equity Incentive Plan [Member] | March 2023 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Increase in issuance of equity-based instruments     1,000,000              
2017 Equity Incentive Plan [Member] | February 2024 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of common stock shares issued     9,000,000              
Increase in issuance of equity-based instruments     3,000,000              
2017 Equity Incentive Plan [Member] | Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of common stock shares issued     485,000              
2025 Long-Term Incentive Plan [Member] | Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of common stock shares issued                 10,000,000